Related Experiment Videos
Meningitis due to Campylobacter fetus intestinalis in a kidney transplant recipient. A case report
1Department of Medicine, University of Minnesota Medical School, Minn.
Abstract:
A 47-year-old man developed Campylobacter fetus intestinalis meningitis 3 years after cadaver renal transplantation. The infection was successfully controlled with chloramphenicol followed by erythromycin. There were no relapses during the past 5 years and the allograft function remains normal. The available evidence suggests that the campylobacter sepsis was associated with nutritional therapy, the patient received in a Mexican clinic. The present case is reported because of its clinical importance and epidemiological implications.
Insights
A kidney transplant patient developed Campylobacter fetus meningitis, successfully treated with antibiotics. This rare case highlights potential infection risks associated with nutritional therapy in transplant recipients.
Area of Science:
- Infectious Diseases
- Nephrology
- Transplantation Immunology
Background:
- Campylobacter fetus intestinalis is a rare cause of meningitis, particularly in immunocompromised individuals.
- Renal transplant recipients are at increased risk for opportunistic infections due to long-term immunosuppression.
Observation:
- A 47-year-old male renal transplant recipient developed meningitis 3 years post-transplantation.
- The patient had received nutritional therapy at a clinic in Mexico prior to symptom onset.
Findings:
- The meningitis was caused by Campylobacter fetus intestinalis.
- Treatment with chloramphenicol followed by erythromycin successfully controlled the infection.
- The patient experienced no relapses over a 5-year follow-up period, with normal allograft function.
Implications:
- This case underscores the importance of considering rare pathogens like C. fetus in transplant recipients with meningitis.
- Nutritional therapy, especially in international settings, may pose an infection risk and warrants careful evaluation.
- Prompt and appropriate antibiotic treatment is crucial for managing C. fetus meningitis in immunocompromised patients.